Eli Lilly and Company is a company in the U.S. stock market and it is a holding in 234 U.S.-traded ETFs. LLY has around 56.8M shares in the U.S. ETF market. The largest ETF holder of LLY is the SPDR S&P 500 ETF Trust (SPY), with approximately 8.18M shares. Investors may also find of interest that the ETF with the largest allocation to LLY stock is Invesco Dynamic Pharmaceuticals ETF (PJP), with a portfolio weight of 5.25%. On average, U.S. ETFs allocate 0.85% of LLY to their portfolios.
Additionally, LLY is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with LLY as a holding is the iShares Morningstar U.S. Equity ETF (ILCB), with a return of 498.40%.